Home / Technical Content / Enzymes to Enable a Biocatalytic Cascade for Small Molecule API

Poster

Enzymes to Enable a Biocatalytic Cascade for Small Molecule API

Enzymes to Enable a Biocatalytic Cascade

For Small Molecule API

Enonereductases (EREDs) and ketoreductases (KREDs) are selective, sustainable alternatives to traditional asymmetric hydrogenation. We developed an ERED/KRED enzymatic cascade to install two stereocenters on a cyclohexyl ring in the synthesis of BMS-986278, a potent LPA1 antagonist. Protein engineering and process optimization led to major efficiency gains and a four-fold reduction in PMI compared to the original non-biocatalytic route. This innovation was recognized with the 2023 Peter J. Dunn Award for its significant green chemistry impact.

Gated content

Please complete the form below to access this content.

Discover the Expertise Powering Possibility

Speak to our experts to learn how our platforms deliver smarter science, faster timelines, and greater confidence. Let’s talk.

graphic

Related content

Pharmaceutical Biocatalysis

Enzyme Screening Kits and Panels

Tailored Enzymes

Want to see more technical content?

graphic

We're Paving Your Path to the Future

You own the product and we own the path. Together, we’ll take it to market clearly, cleanly and without surprises.

graphic